Takaaki Izumi

Efficacy and safety of daclatasvir and asunaprevir combination therapy in chronic hemodialysis patients with chronic hepatitis C

Goki Suda, Mineo Kudo, Atsushi Nagasaka et al. · Journal of Gastroenterology · 2016 · 109 citations · Full text

Medicine, Nephrology, Pharmacotherapy +14

L‐Carnitine Suppresses Loss of Skeletal Muscle Mass in Patients With Liver Cirrhosis

Masatsugu Ohara, Koji Ogawa, Goki Suda et al. · Hepatology Communications · 2018 · 90 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Liver steatosis and dyslipidemia after HCV eradication by direct acting antiviral agents are synergistic risks of atherosclerosis

Naoki Kawagishi, Goki Suda, Akinobu Nakamura et al. · PLoS ONE · 2018 · 56 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Retreatment with sofosbuvir, ledipasvir, and add-on ribavirin for patients who failed daclatasvir and asunaprevir combination therapy

Goki Suda, Koji Ogawa, Yoshiya Yamamoto et al. · Journal of Gastroenterology · 2017 · 35 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +14

Hepatitis B virus X protein impairs α‐interferon signaling via up‐regulation of suppressor of cytokine signaling 3 and protein phosphatase 2A

Seiji Tsunematsu, Goki Suda, Kazushi Yamasaki et al. · Journal of Medical Virology · 2016 · 33 citations

Life Sciences, Infectious Diseases, Molecular Biology +17